Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 10, Issue 1, Pages 51-65
Publisher
Informa Healthcare
Online
2013-10-25
DOI
10.1517/17425255.2014.851667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care
- (2013) Marianne K. DeGorter et al. Circulation-Cardiovascular Genetics
- Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis
- (2013) Bruce K. Birmingham et al. CLINICAL DRUG INVESTIGATION
- Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients
- (2013) Hon-Kit Lee et al. PHARMACOGENOMICS
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- Pharmacokinetic Interaction Between Pitavastatin and Valsartan: A Randomized, Open-Labeled Crossover Study in Healthy Male Korean Volunteers
- (2012) Jin Ah Jung et al. CLINICAL THERAPEUTICS
- Therapeutic options for statin-intolerant patients
- (2012) Michael S. Kostapanos et al. CURRENT MEDICAL RESEARCH AND OPINION
- Statin-Induced Myotoxicity: Pharmacokinetic Differences among Statins and the Risk of Rhabdomyolysis, with Particular Reference to Pitavastatin
- (2012) Alberico L. Catapano Current Vascular Pharmacology
- Effects of Grapefruit Juice and SLCO1B1 388A>G Polymorphism on the Pharmacokinetics of Pitavastatin
- (2012) Miao Hu et al. Drug Metabolism and Pharmacokinetics
- Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans
- (2012) Eun Sil Oh et al. Drug Metabolism and Pharmacokinetics
- Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
- (2012) Jemma C. Hopewell et al. EUROPEAN HEART JOURNAL
- Statin drug interactions and related adverse reactions
- (2012) Stefano Bellosta et al. Expert Opinion On Drug Safety
- The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C
- (2012) Tamio Teramoto EXPERT OPINION ON PHARMACOTHERAPY
- Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult Volunteers
- (2012) Roger E. Morgan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects
- (2012) Roger E. Morgan et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
- (2012) Harshal A. Deshmukh et al. JOURNAL OF LIPID RESEARCH
- Organic Anion-Transporting Polypeptides 1a/1b Control the Hepatic Uptake of Pravastatin in Mice
- (2012) Dilek Iusuf et al. MOLECULAR PHARMACEUTICS
- A clinically significant interaction between warfarin and simvastatin is unique to carriers of theCYP2C9*3allele
- (2012) Marine L Andersson et al. PHARMACOGENOMICS
- The Role of OATP1B1 and BCRP in Pharmacokinetics and DDI of Novel Statins
- (2011) Wen Jin Hua et al. Cardiovascular Therapeutics
- Comparison of the Pharmacokinetics of Pitavastatin by Formulation and Ethnic Group
- (2011) Steve Warrington et al. CLINICAL DRUG INVESTIGATION
- Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis
- (2011) R. Bologa et al. CLINICAL NEPHROLOGY
- Drug–drug interactions with statins: will pitavastatin overcome the statins’ Achilles’ heel?
- (2011) Alberto Corsini et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin
- (2011) Christine Y. Yu et al. CURRENT MEDICAL RESEARCH AND OPINION
- Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects
- (2011) Sam Rebello et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats
- (2011) Jin-Hua Wen et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Drug safety evaluation of rosuvastatin
- (2011) Peter P Toth et al. Expert Opinion On Drug Safety
- Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Pitavastatin on Steady-State Warfarin in Healthy Adult Volunteers
- (2011) Yoichiro Inagaki et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Steady-State Pharmacokinetic Interactions of Darunavir/Ritonavir With Lipid-Lowering Agent Rosuvastatin
- (2011) Divya Samineni et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Differential Effect of Grapefruit Juice on Intestinal Absorption of Statins Due to Inhibition of Organic Anion Transporting Polypeptide and/or P-glycoprotein
- (2011) Yoshiyuki Shirasaka et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy
- (2011) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Impact ofSLCO1B1(OATP1B1) andABCG2(BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins
- (2011) Grant T. Generaux et al. XENOBIOTICA
- Pitavastatin: finding its place in therapy
- (2011) Leiv Ose Therapeutic Advances in Chronic Disease
- Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia
- (2010) Michael S. Kostapanos et al. American Journal of Cardiovascular Drugs
- Pitavastatin – pharmacological profile from early phase studies
- (2010) Alberico L. Catapano ATHEROSCLEROSIS SUPPLEMENTS
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy
- (2010) Yiannis S. Chatzizisis et al. DRUG SAFETY
- The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
- (2010) Miao Hu et al. Expert Opinion on Drug Metabolism & Toxicology
- Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition
- (2010) F. Josephson JOURNAL OF INTERNAL MEDICINE
- Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients
- (2010) Miao Hu et al. Pharmacogenetics and Genomics
- Differential effect of genetic variants of Na+-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors
- (2010) Min-Koo Choi et al. XENOBIOTICA
- No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
- (2009) Jenni E. Keskitalo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins
- (2009) Michael J. Knauer et al. CIRCULATION RESEARCH
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report
- (2009) Jianyong Wu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
- OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers
- (2009) J. Wen et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Myopathy with statin–fibrate combination therapy: clinical considerations
- (2009) Terry A. Jacobson Nature Reviews Endocrinology
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs
- (2009) Alice Cristina Rodrigues et al. PHARMACOGENOMICS
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy
- (2009) S P R Romaine et al. PHARMACOGENOMICS JOURNAL
- Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
- (2008) Csilla Hegedűs et al. ADVANCED DRUG DELIVERY REVIEWS
- The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials
- (2008) K. Josan et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Statin???Drug Interactions
- (2008) William H. Frishman et al. Cardiology in Review
- Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study
- (2008) Wei Zhang et al. CLINICAL THERAPEUTICS
- Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia
- (2008) Tsang-Bin Tzeng et al. CURRENT MEDICAL RESEARCH AND OPINION
- Hepatic Nuclear Factor 1 Inhibitor Ursodeoxycholic Acid Influences Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 Substrate Rosuvastatin and Bilirubin
- (2008) Y.-J. He et al. DRUG METABOLISM AND DISPOSITION
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability
- (2008) John R Crouse Expert Opinion on Drug Metabolism & Toxicology
- The effect of chronic renal failure on drug metabolism and transport
- (2008) Albert W Dreisbach et al. Expert Opinion on Drug Metabolism & Toxicology
- Rosuvastatin: efficacy, safety and clinical effectiveness
- (2008) Handrean Soran et al. EXPERT OPINION ON PHARMACOTHERAPY
- Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan
- (2008) Henry J. Malinowski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15
- (2008) Jian Wei Deng et al. Pharmacogenetics and Genomics
- Global analysis of genetic variation in SLCO1B1
- (2007) Marja K Pasanen et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now